Valion Bio Reports Early Results Showing NMR Potential to Track Microbial Growth
Valion Bio's Velocity Bioworks subsidiary completed an initial feasibility evaluation of LarmorBio's BioScan-NMR platform for biologics manufacturing. Testing showed a strong correlation between nuclear magnetic resonance signals and optical density at 600 nm, a measure of cell density. The early-stage proof of concept